Is maximum tolerated doseMTDchemotherapy scheduling optimal for glioblastoma multiforme
| dc.article.end-page | 21 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1016/J.CNSNS.2024.108292 | en |
| dc.contributor.author | C Yen Kao | en |
| dc.contributor.author | Seyyed Mohammadi | en |
| dc.contributor.author | S Yousefnezhad | en |
| dc.date.accessioned | 2024-09-10T13:51:18Z | |
| dc.date.available | 2024-09-10T13:51:18Z | |
| dc.faculty | FACULTY OF SCIENCE | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 1007-5704 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/40699 | |
| dc.journal.title | Is maximum tolerated doseMTDchemotherapy scheduling optimal for glioblastoma multiforme | en |
| dc.journal.volume | 139 | en |
| dc.publisher | ELSEVIER SCIENCE BV | en |
| dc.school | 5.03 | en |
| dc.title | Is maximum tolerated doseMTDchemotherapy scheduling optimal for glioblastoma multiforme | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 7.31 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client